A Randomized Vehicle-Controlled Trial to Assess the Efficacy, Safety, and Tolerability of Ozenoxacin 1% Cream in 412 Patients 2 Months and Older with Impetigo. (2017). SKIN The Journal of Cutaneous Medicine, 1(3.1), s103. https://doi.org/10.25251/skin.1.supp.102